213 related articles for article (PubMed ID: 11406067)
1. Home versus in-patient treatment for deep vein thrombosis.
Schraibman IG; Milne AA; Royle EM
Cochrane Database Syst Rev; 2001; (2):CD003076. PubMed ID: 11406067
[TBL] [Abstract][Full Text] [Related]
2. Home versus in-patient treatment for deep vein thrombosis.
Othieno R; Abu Affan M; Okpo E
Cochrane Database Syst Rev; 2007 Jul; (3):CD003076. PubMed ID: 17636714
[TBL] [Abstract][Full Text] [Related]
3. Home versus in-patient treatment for deep vein thrombosis.
Othieno R; Okpo E; Forster R
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
[TBL] [Abstract][Full Text] [Related]
4. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis.
Morris TA; Castrejon S; Devendra G; Gamst AC
Chest; 2007 Oct; 132(4):1131-9. PubMed ID: 17646239
[TBL] [Abstract][Full Text] [Related]
5. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
6. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
[TBL] [Abstract][Full Text] [Related]
7. [Evolution in the pharmacological treatment of venous thrombosis according to evidence-based medicine].
Manganaro A; Giannino D; Lembo D; Bruni F; Consolo F
Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):41-51. PubMed ID: 11253339
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis.
Estrada CA; Mansfield CJ; Heudebert GR
J Gen Intern Med; 2000 Feb; 15(2):108-15. PubMed ID: 10672114
[TBL] [Abstract][Full Text] [Related]
9. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures.
Handoll HH; Farrar MJ; McBirnie J; Tytherleigh-Strong G; Milne AA; Gillespie WJ
Cochrane Database Syst Rev; 2002; (4):CD000305. PubMed ID: 12519540
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
[TBL] [Abstract][Full Text] [Related]
11. Once versus twice daily LMWH for the initial treatment of venous thromboembolism.
van Dongen CJ; Mac Gillavry MR; Prins MH
Cochrane Database Syst Rev; 2003; (1):CD003074. PubMed ID: 12535452
[TBL] [Abstract][Full Text] [Related]
12. Thrombolysis for acute deep vein thrombosis.
Watson LI; Armon MP
Cochrane Database Syst Rev; 2004 Oct; (4):CD002783. PubMed ID: 15495034
[TBL] [Abstract][Full Text] [Related]
13. Outpatient management of DVT using low molecular weight heparin and a hospital outreach service.
Rymes NL; Lester W; Connor C; Chakrabarti S; Fegan CD
Clin Lab Haematol; 2002 Jun; 24(3):165-70. PubMed ID: 12067281
[TBL] [Abstract][Full Text] [Related]
14. Could deep vein thrombosis be safely treated at home?
Labas P; Ohradka B; Cambal M
Bratisl Lek Listy; 2001; 102(10):458-61. PubMed ID: 11802292
[TBL] [Abstract][Full Text] [Related]
15. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures.
Handoll HH; Farrar MJ; McBirnie J; Tytherleigh-Strong G; Awal KA; Milne AA; Gillespie WJ
Cochrane Database Syst Rev; 2000; 2002(2):CD000305. PubMed ID: 10796339
[TBL] [Abstract][Full Text] [Related]
16. The effects of location and low-molecular-weight heparin administration on deep vein thrombosis outcomes in trauma patients.
Lee TH; Alonzo BJ; Differding J; Underwood SJ; Hamilton G; Kremenevskiy I; McNamara S; Schreiber MA
J Trauma Acute Care Surg; 2013 Feb; 74(2):476-81. PubMed ID: 23354241
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Büller HR; Agnelli G; Hull RD; Hyers TM; Prins MH; Raskob GE
Chest; 2004 Sep; 126(3 Suppl):401S-428S. PubMed ID: 15383479
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.
Magee KD; Sevcik W; Moher D; Rowe BH
Cochrane Database Syst Rev; 2003; (1):CD002132. PubMed ID: 12535430
[TBL] [Abstract][Full Text] [Related]
19. Outpatient management of venous thromboembolism.
Vanscoy GJ
J Thromb Thrombolysis; 1999 Apr; 7(2):109-12. PubMed ID: 10364775
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Kearon C; Kahn SR; Agnelli G; Goldhaber S; Raskob GE; Comerota AJ
Chest; 2008 Jun; 133(6 Suppl):454S-545S. PubMed ID: 18574272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
